Credence Research, the leading business intelligence provider, has published its latest research, “Drug Eluting Stents Market 2026”, which gives insights into Drug Eluting Stents in the Global market. The report determines the market size for 2018, along with forecasts until 2026. It is built using data and information sourced from exclusive databases, primary and secondary research, and in-house analysis carried out by Credence Research’s team of industry experts.[Continue reading..]

Market Insight: World Health Organization in its 2015 statistics has reported that out of the 17 million premature deaths 82 % of the deaths were from the lower and middle income countries, and 37 % of these were due to cardiovascular diseases. The risk factors identified to be associated to the worsening of the disease etiology related to cardiac complications are, binge drinking, smoking, obesity and type 2 diabetes. It is noteworthy to understand that there are no symptoms in the blood vessel diseases, a heart attack or stroke are considered as warning for the underlying diseases. Drug eluting stents finds importance in the cardiovascular complications as it is a minimally invasive surgical procedure, broadens the constricted blood vessels, and is useful in prolonging the life of the patient.

This research report gives worldwide Drug Eluting Stents volume forecast and recent quarter review of major Drug Eluting Stents vendor performance. The report includes major vendors’ volume, growth trends, revenue and revenue growth trends, operating profit margin and ASP, along with analyst insights.

Depth Information of This report:

Key research study highlights comprise:

  1. Exhaustive research and analysis of the global Drug Eluting Stents industry
  2. The key market segments along have been explained in the report thoroughly along with their existing and estimated market size
  3. Major elements of market dynamics such as drivers, challenges and opportunities and their effect on Drug Eluting Stents market is also covered in the report
  4. Key players operating in the market are profiled and accompanied with the competitive landscape evaluated on the basis of product offering& business strength
  5. Cross sectional analysis of each region covering individual segments for the forecast period 2016 – 2018 in terms of value (US$ Mn)

Research methodology applied for this study:

Methodology of this research study includes primary and secondary research for defining the market size, shares and forecast for global Drug Eluting Stents market specific to key segments, and regional segmentation.

  1. Secondary Research

Secondary research was initiated with data collected through sources such as press releases, company annual reports, and relevant documents focusing on the current developments in the global Drug Eluting Stents market. Authentic sources such as university research papers, scientific journals, and government websites were similarly screened for identifying business opportunities in several geographical markets and penetration of various products/services in these geographies. Paid databases were excavated to assemble information beneficial for broad commercial study of the key players operating in Drug Eluting Stents market. In case lack of data availability on the public domain, we used estimation models to arrive at comprehensive data sets. Secondary research helped to create a firm base to build market size, analyze trends, and understand the dynamics of Drug Eluting Stents market study.

  1. Primary Research

The exhaustive secondary research practiced was supported & validated by extensive primary research. Primary research was carried out with the help ofe-mail interactions, telephonic interviews, as well as face-to-face interviews with the leading industry stakeholders.

The participants tracked for primary interviews include:

  • Marketing/product managers
  • Vice President/ CEOs
  • National sales managers
  • Market intelligence managers
  • Distributors
  • Purchasing managers
  • Other stakeholders


  • The report presents the brief overview of Drug Eluting Stents Market including business description, key information and facts, and its locations and subsidiaries
  • The report features product description and descriptive mechanism of action for key products along with the products developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued projects
  • Latest company statement
  • Latest news and deals relating to the Drug Eluting Stents products

Do inquiry before purchasing the research @

Table of content:

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Drug Eluting Stents Market Portraiture
2.1.1. Global Drug Eluting Stents Market, by Product, 2016 (Value %)
2.1.2. Global Drug Eluting Stents Market, by Application, 2016 (Value %)
2.1.3. Global Drug Eluting Stents Market, by Geography, 2016 (Value %)

Chapter 3. Drug Eluting Stents Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Drug Eluting Stents Market, 2015-2025 (US$ Mn)
3.8. Competitive Landscape : Global Drug Eluting Stents Market, by Key Players 2015-2025 (US$ Mn) …

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Biosensors International Group
7.3. Biotronik
7.4. Boston Scientific Corporation
7.5. Cook Medical
7.6. Lepu Medical Technology
7.7. Medtronics Plc
7.8. Terumo Medical Corporation …

Reasons to Buy

  • The report provides information about technology solutions needed for the implementation of Drug Eluting Stents projects, and allows readers to make effective business decisions
  • The report helps readers to strengthen strategic framework by understanding the business benefits to be achieved through Drug Eluting Stents solutions
  • The report highlights projected investment on Drug Eluting Stents over the next two years. This will help organizations to allocate budget towards Drug Eluting Stents implementation and business expansion
  • The report helps executives plan their adoption of Drug Eluting Stents by providing expected timeframes for implementation

Click Here for TOC and Full report:

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE, CA 95103, US